| Ytd | -26.52% | |
| 1y | 46.49% |
| Open | 6.93 | Prev Close | 6.81 | Low | 6.80 | High | 7.06 | Mkt Cap | 1.02B |
| Vol | 1.06M | Avg Vol | 1.83M | EPS | 0.04 | P/E | 172.26 | Forward P/E | 18.41 |
| Beta | 1.25 | Short Ratio | 5.63 | Inst. Own | 94.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-27 | 50-d Avg | 8.73 | 200-d Avg | 9.32 | 1yr Est | 13.13 |
Technip Energies (OTCMKTS:THNPY - Get Free Report) and Tetra Technologies (NYSE: TTI - Get Free Repo
Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Coliti
Tetra Technologies NYSE: TTI reported second-quarter revenue of $185.7 million, up 19% sequentially
Although the revenue and EPS for Tetra Technologies (TTI) give a sense of how its business performed
TETRA Technologies, Inc. (TTI) Q2 2026 Earnings Call Transcript
Tetra Technologies (TTI) came out with quarterly earnings of $0.08 per share, in line with the Zacks
Although the revenue and EPS for Tetra Technologies (TTI) give a sense of how its business performed
SPRING, Texas, Aug. 3, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYS
STAT3 acts as a convergent node downstream of multiple signaling pathways implicated in ulcerative c
Tetra Technologies (TTI) doesn't possess the right combination of the two key ingredients for a like
SPRING, Texas, July 13, 2026 /PRNewswire/ -- TETRA Technologies, Inc. (NYSE:TTI) will release Second
San Diego, California--(Newsfile Corp. - July 13, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI
Tvardi Therapeutics, Inc. (TVRD) Discusses Phase 1 Data on TTI-109 STAT3 Inhibitor Highlighting Prod
TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions i
Northland Capital Markets analyst Bobby Brooks maintains Tetra Technologies (NYSE:TTI) with a Out
Tetra Technologies (TTI) was a big mover last session on higher-than-average trading volume. The lat
Using Neptune Chemistry to Achieve Required Density With Lower Zinc Content; Awarded Three-Well 20k
Using Neptune Chemistry to Achieve Required Density With Lower Zinc Content; Awarded Three-Well 20k
TETRA Technologies, Inc. (TTI) Presents at J.P. Morgan Natural Resources Conference 2026 Transcript
San Diego, California--(Newsfile Corp. - June 17, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI
VIAV's new TETRA testing upgrade for the CX300 aims to speed deployments, cut costs, and reinforce i
Allows full testing of TETRA MS radios, including transmitter parametric measurements, call processi
Tetra Technologies Inc. (NYSE: TTI) shares fell 15.06% in pre-market trading after announcing a $100
TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) today announced the p
TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) today announced the c
Phase 1 of the Evergreen Project, which included site preparation, power infrastructure, and install
"The Board's approval of the final investment decision for our Arkansas bromine facility mar
Tetra Technologies (NYSE:TTI) reported quarterly earnings of $0.02 per share which met the analyst c
Clear Street analyst Tim Moore downgrades Tetra Technologies (NYSE:TTI) from Buy to Hold and rais
Stifel analyst Stephen Gengaro maintains Tetra Technologies (NYSE:TTI) with a Buy and raises the
Northland Capital Markets analyst Greg Gibas maintains Tetra Technologies (NYSE:TTI) with a Outpe
CJS Securities analyst Jonathan Tanwanteng initiates coverage on Tetra Technologies (NYSE:TTI) wi
Tetra Technologies (NYSE:TTI) raises FY2025 sales outlook from $610.000 million-$630.000 million to
Tetra Technologies (NYSE:TTI) reported quarterly earnings of $0.04 per share which beat the analyst
Analysts say U.S. oil stocks like TTI, PED, and EONR could gain as rising geopolitical risks drive c
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los
U.S. stocks traded lower, with the Dow Jones falling around 40 points on Monday.